Showing 104 of 104on this page. Filters & sort apply to loaded results; URL updates for sharing.104 of 104 on this page
Mechanism of Action: Volasertib (BI 6727)
Volasertib Enhances Sensitivity to TRAIL in Renal Carcinoma Caki Cells ...
Efficacy and tolerability of volasertib in xenograft models of human ...
Volasertib suppresses tumor growth and potentiates the activity of ...
Volasertib cancer drug molecule, illustration - Stock Image - F028/9078 ...
Volasertib inhibits the growth of HCC cells in vitro. A: Chemical ...
Volasertib cancer drug molecule (PLK1 inhibitor). Skeletal formula ...
Structure of PLK1 inhibitor BI-2536 and Volasertib | Download ...
The combined treatment of volasertib and TRAIL induces caspase-mediated ...
Method for Preparing Volasertib and Intermediate thereof - Eureka | Patsnap
(A) MyLa cells were treated with volasertib and BRD4 binding to the ...
Identification of volasertibresistant mechanism and evaluation of ...
Volasertib stimulates caspase-3 activity and induces apoptosis in ...
Volasertib Cancer Drug Molecule Photograph by Molekuul/science Photo ...
Volasertib suppresses entry into prometaphase and leads to prolonged ...
Volasertib molecule skeletal formula Royalty Free Vector
Volasertib accumulates cells in G2/M phase and inhibits mitotic ...
Volasertib molecule plk1 inhibitor formula Vector Image
Volasertib (BI 6727) | PLK1 Inhibitor | MedChemExpress
Establishment of volasertib-resistant cells and resistant mechanism of ...
Volasertib induces cytotoxicity and alters polo‐like kinase (PLK ...
Volasertib prevents bipolar spindle formation, inducing cell cycle ...
The efficacy of volasertib in a series of human hematological malignant ...
Susceptibility to volasertib and baseline expression of polo‐like ...
Volasertib for AML: clinical use and patient consideration | OTT
Co-treatment with volasertib and belinostat suppresses tumor growth in ...
Mechanism of apoptosis in BET inhibitors resistant cells. A. Cell death ...
[PDF] Identification of volasertib-resistant mechanism and evaluation ...
Volasertib overcomes T-DM1 resistance in 3D culture and in vivo ...
(PDF) Efficacy and Mechanism of Action of Volasertib, a Potent and ...
Volasertib decreases tumour growth in JQ1-resistant cells in vivo. A ...
Volasertib - Alchetron, The Free Social Encyclopedia
Belinostat dramatically increases volasertib lethality and inhibits ...
Volasertib cancer drug molecule, illustration - Stock Image - F028/9075 ...
Co-treatment with volasertib and belinostat synergistically induces ...
Combined treatment of volasertib with other agents | Download ...
Arithmetic mean plasma concentration of volasertib over time. BS, free ...
Volasertib and SN38 have clinically relevant absolute IC50s. Volasertib ...
Volasertib inhibits subcutaneous xenograft growth of a... | Download ...
Volasertib sensitizes TRAIL-induced apoptosis in Caki cells. (A,B) Caki ...
Volasertib induces cell cycle arrest at G2/M Phase in HCC cells ...
The combination of volasertib (10 mg/kg) and radiation (10 Gy ...
Volasertib Krebsmedikament Molekül (PLK1-Inhibitor). Skelettmuskulatur ...
Volasertib decreases cells in S phase, accumulates cells in G2/M phase ...
Volasertib arrests AML cells in mitosis, inhibits proliferation, and ...
Volasertib: Uses, Interactions, Mechanism of Action | DrugBank
Volasertib causes cell cycle arrest in G2/M after 72 hours treatment ...
Volasertib Cancer Drug Molecule #6 by Science Photo Library
Volasertib is cytotoxic to AML blasts but at equivalent concentration ...
Volasertib inhibits polo-like kinase 1 (PLK1) signaling and augments ...
Full article: Volasertib for AML: clinical use and patient consideration
Effects of volasertib on cell proliferation, apoptosis and cell cycle ...
Preparation method of Volasertib and intermediates thereof - Eureka ...
Onvansertib and volasertib IC50s (nM) in the different ovarian cancer ...
volasertib | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Growth inhibition upon volasertib treatment is p53‐dependent. (A ...
Volasertib induces premature senescence through, at least partially, a ...
Volasertib enhances the anti-tumor effect of TMZ. (A) Inhibition rate ...
Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and ...
Volasertib overcomes resistance to fulvestrant and palbociclib in MCF7 ...
Volasertib as single agent and in combination with entinostat exert ...
Sepantronium synergizes with volasertib in killing of different ...
Response to volasertib in CCND1-driven PDX a clinical history, genomic ...
Polo-like kinase 1 inhibitors GSK461364 and volasertib selectively ...
H1299 cells were treated with DMSO, sepantronium (20 nM), volasertib ...
Volasertib induces apoptosis in HCC cells. BEL7402 (A) and HepG2 (B ...
(PDF) Volasertib as a monotherapy or in combination with azacitidine in ...
At the B3LYP/DFT level of theory, an optimized structure of Volasertib ...
Volasertib, a PLK1 Inhibitor, Can be Used for Solid Tumors Research ...
Vincristine/Volasertib Polymersome Injection Enables High-Efficiency ...
Structures of PLK inhibitors BI 2536 and volasertib, and design of ...
Chemical and X-ray structure of volasertib. Chemical structure (a) and ...
The volasertib/belinostat regimen induces mitotic arrest, frequent ...
A Cereblon Modulator CC-885 Induces CRBN- and p97-Dependent PLK1 ...
mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC | Oncotarget
T-DM1/volasertib combination leads to apoptosis and DNA damage in a ...
MDR1 expression was associated with volasertib-resistance. (A) The ...
